Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;20(6):811-828.
doi: 10.1007/s13770-023-00560-x. Epub 2023 Aug 31.

Biotherapeutic Applications of Platelet-Rich Plasma in Regenerative Medicine

Affiliations
Review

Biotherapeutic Applications of Platelet-Rich Plasma in Regenerative Medicine

Maria Ruth Pineda-Cortel et al. Tissue Eng Regen Med. 2023 Oct.

Abstract

Background: Platelet-rich plasma (PRP), a blood-based product containing platelets and growth factors, is being utilized to treat numerous non-hemostatic disorders. Studies have explored the use of PRP to provide rapid repair, healing, and recovery from various injuries; some studies mentioned the effectiveness of PRP as compared with other forms of treatment like the use of hyaluronic acid. Commercially available PRP systems are available now, and each varies from one another depending on how it is prepared, thus causing variations in platelet concentration and growth factor content. These variations also implicated different therapeutic applications.

Methods: The paper reviews the various applications of PRP, including factors to consider before using PRP therapy, and provides an extensive list of PRP applications.

Results: The administration of PRP as a standalone treatment or as a co-therapy results in observed positive outcomes. However, there is a lack of standardization for PRP preparation, increasing the risks for heterogeneity and bias amongst results.

Conclusion: The use of PRP is indeed an option for regenerative therapy, but more research is needed before it can fully be recommended as a primary treatment modality.

Keywords: Biotherapy; Platelet; Platelet-rich plasma; Regenerative medicine; Treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
The current uses of PRP as a treatment. When an injury has occurred, activated platelets (A) release growth factors (B) for connective tissue regeneration, cell growth, cell differentiation, and angiogenesis. In musculoskeletal injuries (C) and chronic wounds (D), growth factors played a significant role in regeneration and effectiveness in hemostasis, tissue repair, and reduction of healing time. These growth factors found in PRP are also impressive when used as a dental implant (F) in dental cell regeneration and as well in hair regrowth (E)

References

    1. dos Santos RG, Santos GS, Alkass N, et al. The regenerative mechanisms of platelet-rich plasma: a review. Cytokine. 2021;144:155560. doi: 10.1016/j.cyto.2021.155560. - DOI - PubMed
    1. Chen PH, Chen X, He X. Platelet-derived growth factors and their receptors: structural and functional perspectives. Biochim Biophys Acta. 2013;1834:2176–2186. doi: 10.1016/j.bbapap.2012.10.015.Platelet-derived. - DOI - PMC - PubMed
    1. Ren M, Zhong X, Ma CY, et al. Insulin-like growth factor-1 promotes cell cycle progression via upregulation of cyclin D1 expression through the phosphatidylinositol 3-kinase/nuclear factor-kB signaling pathway in FRTL thyroid cells. Acta Pharmacol Sin. 2009;30:113–119. doi: 10.1038/aps.2008.8. - DOI - PubMed
    1. Gan QF, Choy KW, Foo CN, Leong PP, Cheong SK. Incorporating insulin growth Factor-1 into regenerative and personalised medicine for musculoskeletal disorders: a systematic review. J Tissue Eng Regen Med. 2021;15:419–441. doi: 10.1002/term.3192. - DOI
    1. Poniatowski LA, Wojdasiewicz P, Gasik R, Szukiewicz D. Transforming growth factor beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications. Mediat Inflamm. 2015 doi: 10.1155/2015/137823. - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources